Califf Nomination Could Show Confidence In Bipartisan Appeal
This article was originally published in The Tan Sheet
After seven months as deputy commissioner for medical products and tobacco, Robert Califf is nominated as FDA commissioner. The nomination goes through the Senate Health, Education, Labor and Pensions Committee before heading to the floor for a full Senate vote.
You may also be interested in...
Renowned cardiologist and clinical trial researcher Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco. Califf is director of Duke University’s Translational Medicine Institute and vice chancellor for Clinical and Translational Research.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.